Luspatercept and Lenalidomide (L2)

A Multicenter, Phase Ib/II Study That Combines Luspatercept and Lenalidomide (L2) in Lower-risk, Non-del(5q) MDS Patients

Near Add Your Location

Sorting 7 by

Center of Excellence

Sylvester Comprehensive Cancer Center (Main)
University of Miami Health System
Miami, FL
  • Not currently accepting

Center of Excellence

Moffitt Cancer Center
Magnolia Campus
Tampa, FL
  • Not currently accepting

Center of Excellence

Sidney Kimmel Comprehensive Cancer Center
Johns Hopkins Medicine
Baltimore, MD
  • Not currently accepting

Center of Excellence

Dana-Farber Cancer Institute
Boston, MA
  • Not currently accepting

Center of Excellence

Weill Cornell
New York, NY
  • Not currently accepting

Center of Excellence

Cleveland Clinic - Taussig Cancer Center
Taussig Cancer Institute
Cleveland, OH
  • Not currently accepting

Center of Excellence

The University of Texas Southwestern Medical Center
Harold C. Simmons Comprehensive Cancer Center
Dallas, TX
  • Not currently accepting

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print a patient-friendly report to share with your patient.

(888) 803-1766

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.